On the heels of the WINTHER study, the consortium has planned a new trial called MERCURY, and will launch a blood and tissue repository.
The company immediately borrowed $255 million to pay part of the $680 million price tag for Alere's MeterPro cardiovascular and toxicology business and its BNP assay business.
The new funds follow a $3.3 million Series C financing round closed in late 2009. MDI will use the money to further develop its pipeline of qualitative real-time PCR in vitro diagnostic tests for infectious diseases.
Duke researchers and the SAEC will use whole-genome sequencing to identify and validate rare gene variants associated with clozapine-induced immunological response.
Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.
According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.
In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.
CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.